Back

Predictors of early renal dysfunction after heart transplantation: a report from the International Consortium on Primary Graft Dysfunction

26 August 2022 (16:15 - 17:00)
Organised by:
Congress Presentation Part of: Heart transplantation Heart Transplantation ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Joan Guzman Bofarull

Harefield Hospital, Royal Brompton and Harefield NHS Foundation Trust, London (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Characteristics, predictors and outcomes of early mTOR inhibitor use after heart transplantation: insights from the UNOS database
Assistant Professor A. Briasoulis (Athens, GR)
Abstract Slides
Presentation thumbnail
Outcomes of patients after repeat heart transplantation - Insights from the UNOS database
Assistant Professor A. Briasoulis (Athens, GR)
Abstract Slides
Presentation thumbnail
Gender mismatch and outcomes following heart transplantation in the United States
Assistant Professor A. Briasoulis (Athens, GR)
Abstract Slides
Presentation thumbnail
Impact of co-morbidities on survival after heart transplant in females of childbearing age: analysis of the International Society for Heart and Lung Transplantation (ISHLT) Registry
Doctor F. macera (Milan, IT)
Abstract Slides
Presentation thumbnail
T1 mapping of the right ventricle in heart transplant recipients: how does it correlate with endomyocardial biopsy findings?
Professor L. Sade (Pittsburgh, US)
Abstract Slides

Access the full session

Session thumbnail
Heart transplantation

The Event

Event poster

ESC Congress 2022

26 August 2022 16:15 CET
You may be interested in
thumbnail
Congress Session
Navigating through heart failure device therapies
thumbnail
Congress Session
Advanced heart failure, mechanical circulatory support, and transplant
thumbnail
Congress Presentation
From heart transplant prioritization to functional and echocardiographic improvement: the impact of in-hospital cardiac rehabilitation in advanced ischemic heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources